1 of 5
A 60-year-old African American male with Stage C HFrEF and NYHA class III symptoms is currently treated with an ACE inhibitor, a beta blocker, and a loop diuretic. Despite this, he continues to experience marked exercise intolerance. Which additional treatment should be considered for this patient?